After a deal between Dynagen, a biotechnology firm developing a cure for multiple sclerosis, and venture capitalist Drew Lispenard falls through, murder strikes aboard a Dynagen executive's boat, and Drew investigates
CERTAIN CONTENT THAT APPEARS ON THIS PAGE COMES FROM AMAZON. THIS CONTENT IS PROVIDED ‘AS IS’ AND IS SUBJECT TO CHANGE OR REMOVAL AT ANY TIME.